Showing results (371-380 of 390) with videos related to

Sort By:
Pageof 39
American Journal of Hematology|April 6, 2026
Efficacy and Safety of Subcutaneous Efgartigimod PH20 in Adults With Primary Immune Thrombocytopenia (ADVANCE SC): A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 3 TrialNichola Cooper, Catherine M Broome, Yoshitaka Miyakawa, et al.
British Journal of Haematology|July 22, 2014
A novel canine model of immune thrombocytopenia: has immune thrombocytopenia (ITP) gone to the dogs?Dana N LeVine, Adam J Birkenheuer, Marjory B Brooks, et al.
Blood|November 14, 2008
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupFrancesco Rodeghiero, Roberto Stasi, Terry Gernsheimer, et al.
Lancet (London, England)|August 2, 2015
Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trialJohn D Grainger, Franco Locatelli, Thirachit Chotsampancharoen, et al.
American Journal of Hematology|April 8, 2017
Clinical outcomes in a cohort of patients with heparin-induced thrombocytopeniaDavid J Kuter, Barbara A Konkle, Taye H Hamza, et al.
Blood|September 29, 2021
SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITPEun-Ju Lee, Marina Beltrami-Moreira, Hanny Al-Samkari, et al.
The Lancet. Haematology|December 22, 2015
Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled studyJames B Bussel, Purificación Garcia de Miguel, Jenny M Despotovic, et al.
Blood|December 15, 2005
Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpuraCarolyn M Bennett, Zora R Rogers, Daniel D Kinnamon, et al.
Blood Advances|November 27, 2019
Updated international consensus report on the investigation and management of primary immune thrombocytopeniaDrew Provan, Donald M Arnold, James B Bussel, et al.
Pediatric Blood & Cancer|October 22, 2008
One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximabBrigitta U Mueller, Carolyn M Bennett, Henry A Feldman, et al.
Pageof 39